A phase II trial of weekly docetaxel for second-line treatment of urothelial carcinoma.
Young Saing Kim
No relevant relationships to disclose
Moon Ki Choi
No relevant relationships to disclose
Jung Yong Hong
No relevant relationships to disclose
Chi Hoon Maeng
No relevant relationships to disclose
Soonil Lee
No relevant relationships to disclose
In Gyu Hwang
No relevant relationships to disclose
Sang-Cheol Lee
No relevant relationships to disclose
Jong-Mu Sun
No relevant relationships to disclose
Se Hoon Park
No relevant relationships to disclose
Jeeyun Lee
No relevant relationships to disclose
Ho Yeong Lim
No relevant relationships to disclose